Description

The MONOCRYL® Plus Antibacterial Suture (Undyed) by Ethicon, a part of Johnson & Johnson, is a high-quality surgical suture designed for effective wound closure. Crafted from a copolymer of glycolide and epsilon-caprolactone, known as Poliglecaprone 25, this suture is absorbable and undyed, making it suitable for a variety of surgical applications where discretion is desired.

Antibacterial Properties

A key feature of this suture is its coating with IRGACARE® MP, which contains Triclosan. This provides broad-spectrum antibacterial protection against common surgical site infection pathogens such as Staphylococcus aureus, MRSA, and Escherichia coli. This antibacterial property helps in reducing the risk of postoperative infections, promoting safer healing outcomes.

Absorption and Tensile Strength

The suture is designed to be fully absorbed within 91 to 119 days, aligning with the healing process of many soft tissues. Its tensile strength retention is strategically planned: retaining approximately 50-60% strength at 7 days, 20-30% at 14 days, and losing all strength by 21 days. This gradual loss of strength is ideal for tissues that require temporary support during the initial healing phase.

Intended Use

MONOCRYL® Plus is intended for general soft tissue approximation and ligation, where an absorbable suture is indicated. It is not recommended for extended tissue approximation under stress or for closing fascial tissue. Surgeons should consider supplemental nonabsorbable sutures for sites needing prolonged support.

Needle Configurations

The suture is available in various sizes and lengths, with multiple needle types such as PS-2, PS-1, and SH, offering versatility for different surgical needs. Each configuration is packaged in boxes containing either 12 or 36 strands, depending on the specific setup.

Sterilization and Handling

Sterilized using ethylene oxide, the suture is intended for single use only. Proper storage at or below 25°C is essential, and any opened or damaged packages should be discarded to maintain sterility.

Regulatory Compliance

This product complies with the European Pharmacopoeia and United States Pharmacopeia requirements for absorbable surgical sutures, and it is CE marked, ensuring adherence to high-quality standards. Its use is contraindicated in certain patient populations, such as those who are elderly, malnourished, or have delayed wound healing.

Storage Instructions

Healthcare professionals are advised not to resterilize the suture and to avoid prolonged contact with salt solutions to prevent calculus formation. Adhering to these guidelines will help in achieving optimal surgical outcomes.